Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/8/2025

Management of Mast Cell Activation Syndrome with Liver Involvement

Diagnostic Approach

  • The American Gastroenterological Association recommends confirming MCAS diagnosis by measuring serum tryptase levels at baseline and 1-4 hours following symptom flares, looking for increases of 20% above baseline plus 2 ng/mL 1, 2
  • The European Association for the Study of the Liver suggests evaluating liver function with comprehensive liver function tests during both symptomatic and asymptomatic periods 3
  • Consider referral to an allergy specialist or mast cell disease research center for additional testing once MCAS diagnosis is supported by clinical and laboratory findings, as recommended by the American Gastroenterological Association 1, 2
  • Rule out other causes of liver dysfunction through appropriate testing, as MCAS can coexist with other liver conditions, according to the European Association for the Study of the Liver 3

Treatment Approach

  • The American Academy of Allergy, Asthma, and Immunology recommends using H1 receptor antagonists (cetirizine, fexofenadine) at higher doses (2-4 times FDA-approved doses) to reduce inflammation and pain 4
  • Adding H2 receptor antagonists (famotidine) can enhance control by blocking additional histamine pathways, as suggested by the American Academy of Allergy, Asthma, and Immunology 4
  • Implement dietary modifications similar to the Mediterranean dietary pattern, limiting consumption of ultra-processed foods rich in sugars and saturated fats, as recommended by the European Association for the Study of the Liver 3
  • Recommend physical activity (>150 min/week of moderate or 75 min/week of vigorous-intensity) to reduce liver inflammation, according to the European Association for the Study of the Liver 3

Monitoring and Follow-up

  • Use non-invasive tests to monitor liver fibrosis progression in a tailored fashion, as suggested by the European Association for the Study of the Liver 3
  • Adjust therapy based on specific mediator elevations (e.g., if only histamine products are elevated, focus on antihistamines; if prostaglandins are elevated, consider aspirin), as recommended by the American Academy of Allergy, Asthma, and Immunology 4

Important Considerations and Precautions

  • Avoid known triggers of mast cell activation, which may include certain medications, foods, temperature extremes, and stress, as recommended by the American Academy of Allergy, Asthma, and Immunology 4, 5
  • Use opioids with caution as they can trigger mast cell activation, though they should not be withheld if needed since pain itself can trigger mast cell degranulation, according to the American Academy of Allergy, Asthma, and Immunology 5

Multidisciplinary Approach

  • Implement a multidisciplinary approach involving allergy specialists, gastroenterologists, and hepatologists, as recommended by the American Gastroenterological Association and the American Academy of Allergy, Asthma, and Immunology 1, 5
  • Given the connections between liver disease and other comorbidities, ensure all components are appropriately targeted to improve both liver-related and extrahepatic outcomes, according to the European Association for the Study of the Liver 3